Page 2
References
Ataoğlu, H. E., Ahbab, S., Serez, M. K., Yamak, M., Kayaş, D., Canbaz, E. T., Çetin, F., Seçmeler, Ş., Şar, F., & Yenigün, M. (2018). Prognostic significance of high free T4 and low free T3 levels in non-thyroidal illness syndrome. European Journal of Internal Medicine. https://doi.org/10.1016/j.ejim.2018.07.018
Baloch, Z., Carayon, P., Conte-Devolx, B., Demers, L. M., Feldt-Rasmussen, U., Henry, J.-F., LiVolsi, V. A., Niccoli-Sire, P., John, R., Smyth, P. P., Spencer, C. A., & Stockigt, J. R. (2003). Laboratory Support for the Diagnosis and Monitoring of Thyroid Disease. Thyroid, 13(1), 3–3. https://doi.org/10.1089/105072503321086962
Beck-Peccoz, P., Rodari, G., Giavoli, C., & Lania, A. (2017). Central hypothyroidism—A neglected thyroid disorder. Nature Reviews. Endocrinology, 13(10), 588–598. https://doi.org/10.1038/nrendo.2017.47
Bianco, A. C., Dumitrescu, A., Gereben, B., Ribeiro, M. O., Fonseca, T. L., Fernandes, G. W., & Bocco, B. M. L. C. (2019). Paradigms of Dynamic Control of Thyroid Hormone Signaling. Endocrine Reviews, 40(4), 1000–1047. https://doi.org/10.1210/er.2018-00275
Burmeister, L. A. (1995). Reverse T3 does not reliably differentiate hypothyroid sick syndrome from euthyroid sick syndrome. Thyroid : Official Journal of the American Thyroid Association, 5(6), 435.
Cannon, R. O. (2009). Microvascular Angina and the Continuing Dilemma of Chest Pain with Normal Coronary Angiograms. Journal of the American College of Cardiology, 54(10), 877–885. https://doi.org/10.1016/j.jacc.2009.03.080
Davis, P. J., Leonard, J. L., Lin, H.-Y., Leinung, M., & Mousa, S. A. (2018). Molecular Basis of Nongenomic Actions of Thyroid Hormone. Vitamins and Hormones, 106, 67–96. https://doi.org/10.1016/bs.vh.2017.06.001
Davis, P. J., Lin, H.-Y., Hercbergs, A. A., Keating, K. A., & Mousa, S. A. (2019). How thyroid hormone works depends upon cell type, receptor type, and hormone analogue: Implications in cancer growth. Discovery Medicine, 27(147), 111–117.
Farwell, A. P. (1997). Sick Euthyroid Syndrome. Journal of Intensive Care Medicine, 12(5), 249–260. https://doi.org/10.1177/088506669701200505
Fliers, E., Bianco, A. C., Langouche, L., & Boelen, A. (2015). Endocrine and metabolic considerations in critically ill patients. The Lancet. Diabetes & Endocrinology, 3(10), 816–825. https://doi.org/10.1016/S2213-8587(15)00225-9
Garber, J. R., Cobin, R. H., Gharib, H., Hennessey, J. V., Klein, I. L., Mechanick, J. I., Pessah-Pollack, R., Singer, P. A., & Woeber, K. A. (2012). Clinical practice guidelines for hypothyroidism in adults: Cosponsored by the American Association of Clinical Endocrinologists and the American Thyroid Association. Endocrine Practice, 18(6), 988–1028. https://doi.org/10.4158/EP12280.GL
Gomes-Lima, C. J., & Burman, K. D. (2018). Reverse T3 or perverse T3? Still puzzling after 40 years. Cleveland Clinic Journal of Medicine, 85(6), 450–455. https://www.mdedge.com/ccjm/article/166547/endocrinology/reverse-t3-or-perverse-t3-still-puzzling-after-40-years
Gullo, D., Latina, A., Frasca, F., Le Moli, R., Pellegriti, G., & Vigneri, R. (2011). Levothyroxine Monotherapy Cannot Guarantee Euthyroidism in All Athyreotic Patients. PLoS ONE, 6(8). https://doi.org/10.1371/journal.pone.0022552
Hercbergs, A. (2019). Clinical Implications and Impact of Discovery of the Thyroid Hormone Receptor on Integrin αvβ3–A Review. Frontiers in Endocrinology, 10. https://doi.org/10.3389/fendo.2019.00565
Langouche, L., Jacobs, A., & Van den Berghe, G. (2019). Nonthyroidal Illness Syndrome Across the Ages. Journal of the Endocrine Society, 3(12), 2313–2325. https://doi.org/10.1210/js.2019-00325
Larisch, R., Midgley, J. E. M., Dietrich, J. W., & Hoermann, R. (2018). Symptomatic Relief is Related to Serum Free Triiodothyronine Concentrations during Follow-up in Levothyroxine-Treated Patients with Differentiated Thyroid Cancer. Experimental and Clinical Endocrinology & Diabetes: Official Journal, German Society of Endocrinology [and] German Diabetes Association, 126(9), 546–552. https://doi.org/10.1055/s-0043-125064
Lin, H.-Y., Tang, H.-Y., Leinung, M., Mousa, S. A., Hercbergs, A., & Davis, P. J. (2019). Action of Reverse T3 on Cancer Cells. Endocrine Research, 1–5. https://doi.org/10.1080/07435800.2019.1600536
Midgley, J. E. M., Larisch, R., Dietrich, J. W., & Hoermann, R. (2015). Variation in the biochemical response to l-thyroxine therapy and relationship with peripheral thyroid hormone conversion efficiency. Endocrine Connections, 4(4), 196–205. https://doi.org/10.1530/EC-15-0056
Maia, A. L., Goemann, I. M., Meyer, E. L. S., & Wajner, S. M. (2011). Type 1 iodothyronine deiodinase in human physiology and disease. Journal of Endocrinology, 209(3), 283. https://doi.org/10.1530/JOE-10-0481
Rhee, C. M., Brent, G. A., Kovesdy, C. P., Soldin, O. P., Nguyen, D., Budoff, M. J., Brunelli, S. M., & Kalantar-Zadeh, K. (2015). Thyroid functional disease: An under-recognized cardiovascular risk factor in kidney disease patients. Nephrology Dialysis Transplantation, 30(5), 724–737. https://doi.org/10.1093/ndt/gfu024
Wadwekar, D., & Kabadi, U. M. (2004). Thyroid hormone indices during illness in six hypothyroid subjects rendered euthyroid with levothyroxine therapy. Experimental and Clinical Endocrinology & Diabetes: Official Journal, German Society of Endocrinology [and] German Diabetes Association, 112(7), 373–377. https://doi.org/10.1055/s-2004-821012
Warner, M. H., & Beckett, G. J. (2010). Mechanisms behind the non-thyroidal illness syndrome: An update. The Journal of Endocrinology, 205(1), 1–13. https://doi.org/10.1677/JOE-09-0412